Hence, we profiled proliferation of cells treated with the brain penetrant PI3K/Akt inhibitor paxalisib using DIPG, and nonmidline pediatric HGG cell lines (glioblastoma) (Figure 1B). Here, PIK3CA is linked to glioblastoma.